Trials / Completed
CompletedNCT01051037
Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
Phase II Study Evaluating Safety and Efficacy of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable and Recurrent Lung Tumors Near Central Airways
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Jonsson Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that combined stereotactic body radiotherapy and radiofrequency ablation is safe for patients with lung tumors near central airways.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Body Radiation | 3 fraction of stereotactic body radiation therapy within 10 days. |
| RADIATION | Radiofrequency Ablation | Subject will undergo radiofrequency ablation within 10 days of the last fraction of SBRT. |
Timeline
- Start date
- 2010-02-08
- Primary completion
- 2017-12-20
- Completion
- 2017-12-20
- First posted
- 2010-01-18
- Last updated
- 2019-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01051037. Inclusion in this directory is not an endorsement.